A-a Gradient Calculator
Calculates the alveolar-arterial oxygen gradient (A-a gradient) from arterial blood gas values. Differentiates hypoxaemia caused by intrinsic pulmonary pathology (elevated gradient) from extrapulmonary causes such as hypoventilation (normal gradient). Includes age-adjusted expected normal and altitude-adjustable atmospheric pressure.
Calculate A-a Gradient
Enter the patient’s age and arterial blood gas (ABG) values. FiO₂ defaults to 21% (room air) — adjust if the patient is on supplemental oxygen. Atmospheric pressure defaults to 760 mmHg (sea level) and can be modified for altitude.
The A-a gradient is most clinically useful on room air (FiO₂ 21%). At higher FiO₂ values, the gradient increases non-linearly even in healthy lungs, making interpretation less reliable. When supplemental oxygen is in use, the PaO₂/FiO₂ (P/F) ratio is generally preferred for assessing oxygenation efficiency.
Understanding the A-a Gradient
The alveolar-arterial (A-a) oxygen gradient measures the difference between the partial pressure of oxygen in the alveoli (PAO₂, calculated) and the partial pressure of oxygen in arterial blood (PaO₂, measured from ABG). In a perfectly efficient lung, these values would be nearly identical. In reality, a small physiological gradient exists due to normal ventilation-perfusion (V/Q) mismatch and bronchial circulation, but a widened gradient indicates impaired gas exchange at the pulmonary level.
The gradient’s fundamental clinical question is simple: is this patient hypoxaemic because their lungs are not transferring oxygen properly, or because they are not ventilating adequately? A normal A-a gradient with hypoxaemia points to hypoventilation or low inspired oxygen; an elevated gradient points to intrinsic lung pathology.
Alveolar Gas Equation
PAO₂ =
FiO₂ × (Patm − PH₂O) − PaCO₂ / RQ
PH₂O = 47 mmHg (at 37°C)
RQ = 0.8 (standard mixed diet)
Patm = 760 mmHg (sea level)
A-a Gradient = PAO₂ − PaO₂
Worked Example
A 65-year-old on room air (FiO₂ 0.21), PaO₂ 72 mmHg, PaCO₂ 40 mmHg, at sea level:
PAO₂ = 0.21 × (760 − 47) − (40 / 0.8)
= 0.21 × 713 − 50
= 149.7 − 50 = 99.7 mmHg
A-a Gradient = 99.7 − 72 = 27.7 mmHg
Expected for age 65: (65/4) + 4 = 20.3 mmHg
→ Elevated (suggests pulmonary pathology)
Age-adjusted expected A-a gradient: The normal A-a gradient increases with age due to progressive V/Q mismatch and declining diffusion capacity. The most commonly used formula for the approximate upper limit of normal is: Expected A-a gradient = (Age ÷ 4) + 4. An alternative formula used in some references is: 2.5 + (0.21 × Age). Both yield similar results.
Interpretation & Clinical Categories
The key clinical decision point is whether the A-a gradient is normal or elevated relative to the patient’s age. This distinction directs the differential diagnosis of hypoxaemia into two fundamentally different pathways.
| A-a Gradient | Interpretation | Primary Causes of Hypoxaemia |
|---|---|---|
| Normal (≤ expected for age) | Gas exchange is intact — lungs are transferring oxygen normally | Hypoventilation (CNS depression, neuromuscular disease, obesity hypoventilation); Low FiO₂ (high altitude) |
| Mildly Elevated (1–2× expected) | Mild impairment in gas exchange — early or mild pulmonary pathology | Early pneumonia, mild PE, atelectasis, early interstitial lung disease, age-related V/Q changes |
| Significantly Elevated (> 2× expected) | Substantial gas exchange impairment — significant pulmonary pathology | V/Q mismatch (PE, pneumonia, ARDS); Diffusion impairment (ILD, emphysema); Right-to-left shunt (intracardiac, intrapulmonary) |
The most high-yield use of the A-a gradient is in the hypoxaemic patient with a normal gradient — this rapidly narrows the differential to hypoventilation or low inspired oxygen, both of which have specific and targetable causes. A normal A-a gradient in a hypoxaemic patient effectively rules out significant intrinsic lung disease as the cause and redirects the workup toward the respiratory drive, chest wall mechanics, or environmental oxygen content.
Differential Diagnosis by A-a Gradient
The A-a gradient divides causes of hypoxaemia into two main categories: those with a normal gradient (extrapulmonary) and those with an elevated gradient (intrapulmonary). Understanding the mechanisms behind each category guides workup and management.
Normal A-a Gradient — Extrapulmonary Causes
Hypoventilation causes hypoxaemia by reducing alveolar oxygen replacement — CO₂ accumulates and displaces O₂ in the alveolar gas mixture. The lungs themselves are normal, so the A-a gradient remains within the expected range. The hallmark ABG pattern is hypoxaemia with hypercapnia (elevated PaCO₂) and a normal A-a gradient.
Common causes include CNS depression (opioids, benzodiazepines, anaesthetic agents, brainstem pathology), neuromuscular disease (Guillain-Barré, myasthenia gravis, motor neurone disease, phrenic nerve palsy), chest wall abnormalities (kyphoscoliosis, flail chest, massive pleural effusion), and obesity hypoventilation syndrome. Each of these conditions impairs the mechanics or drive of ventilation without affecting the lung parenchyma itself.
A critical clinical application: if a patient presents with respiratory failure, hypercapnia, and a normal A-a gradient, the clinician can be confident that the primary problem is ventilatory failure — not lung disease — and should direct the workup accordingly (neurological examination, drug screen, respiratory muscle assessment).
At high altitude, atmospheric pressure is reduced, which proportionally decreases the partial pressure of inspired oxygen even though the fraction of oxygen remains 21%. For example, at 3,000 metres (approximately 10,000 feet), atmospheric pressure drops to roughly 520 mmHg, and PAO₂ falls from ~100 mmHg at sea level to ~60 mmHg. The A-a gradient remains normal because gas exchange efficiency is preserved — there is simply less oxygen available to transfer.
Similar pathophysiology occurs in enclosed spaces with oxygen depletion (house fires, industrial accidents, confined spaces with combustion) or accidental connection to hypoxic gas mixtures. These are rare but critical diagnoses that the A-a gradient helps identify: hypoxaemia with a normal gradient and normal PaCO₂ should prompt assessment of the inspired oxygen source and environment.
Elevated A-a Gradient — Intrapulmonary Causes
Ventilation-perfusion (V/Q) mismatch is by far the most common cause of an elevated A-a gradient. In a normal lung, ventilation and perfusion are well matched across lung zones. When areas of lung are perfused but poorly ventilated (low V/Q — “shunt-like” units) or ventilated but poorly perfused (high V/Q — “dead space” units), the efficiency of gas exchange declines and the A-a gradient widens.
Causes of V/Q mismatch include pneumonia (consolidated but perfused alveoli), pulmonary embolism (ventilated but unperfused segments), asthma and COPD exacerbations (heterogeneous airway obstruction), atelectasis (collapsed but perfused lung), and pleural effusions compressing adjacent parenchyma. The key feature distinguishing V/Q mismatch from true shunt is that V/Q mismatch typically responds to supplemental oxygen — increasing FiO₂ raises PAO₂ in the ventilated units, improving arterial oxygenation.
A right-to-left shunt occurs when blood passes from the right side of the circulation to the left without encountering ventilated alveoli. This may be intracardiac (e.g., patent foramen ovale with right-to-left flow, Eisenmenger syndrome, ventricular septal defect) or intrapulmonary (e.g., arteriovenous malformations, hepatopulmonary syndrome, severe ARDS with complete alveolar flooding).
The defining characteristic of true shunt is that hypoxaemia does not correct with supplemental oxygen — even at FiO₂ 100%, the shunted blood never contacts ventilated alveoli. If a patient has a markedly elevated A-a gradient that fails to improve with high-flow oxygen, shunt physiology should be suspected. Bubble echocardiography with agitated saline can help distinguish intracardiac from intrapulmonary shunts based on the timing of bubble appearance in the left heart.
Diffusion impairment occurs when the alveolar-capillary membrane is thickened or destroyed, reducing the rate at which oxygen can cross into pulmonary capillary blood. This is the primary mechanism in interstitial lung diseases (idiopathic pulmonary fibrosis, sarcoidosis, hypersensitivity pneumonitis), severe emphysema (loss of alveolar surface area), and pulmonary oedema (fluid in the interstitium).
Clinically, diffusion impairment often manifests as exertional hypoxaemia — at rest, blood transit time through the pulmonary capillary is long enough for adequate oxygen transfer, but during exercise, shortened transit time exposes the diffusion limitation. This pattern — normal or near-normal resting PaO₂ with desaturation on exertion — is characteristic. DLCO (diffusion capacity for carbon monoxide) on pulmonary function testing is the standard measure of this mechanism.
Hypoxaemia + Normal A-a gradient + High PaCO₂ → Hypoventilation. Check: drug screen, neurological exam, respiratory muscle strength.
Hypoxaemia + Elevated A-a gradient + Corrects with O₂ → V/Q mismatch. Check: CXR, CT, PE workup.
Hypoxaemia + Elevated A-a gradient + Does NOT correct with O₂ → Shunt. Check: bubble echo, CT angiography.
Common Pitfalls & Limitations
The A-a gradient is a powerful clinical tool, but its utility depends on correct inputs, appropriate clinical context, and understanding of its limitations.
The A-a gradient is best validated and most clinically useful on room air (FiO₂ 21%). At higher FiO₂ levels, the gradient increases non-linearly even in healthy lungs due to absorption atelectasis, altered nitrogen splinting, and the non-linear shape of the oxygen-haemoglobin dissociation curve. At FiO₂ 100%, a “normal” A-a gradient may be as high as 60–70 mmHg.
When patients are on supplemental oxygen, the PaO₂/FiO₂ (P/F) ratio is a more reliable metric for assessing oxygenation efficiency. A P/F ratio < 300 suggests acute lung injury, and < 200 meets the Berlin criteria for ARDS. If an A-a gradient is calculated on supplemental oxygen, interpret the result with caution and document the FiO₂ used.
The actual FiO₂ delivered by nasal cannula is highly variable and depends on flow rate, the patient’s respiratory rate, tidal volume, and mouth breathing. The commonly cited “4% per litre” rule (21% + 4% per L/min) is a rough approximation at best. A patient breathing at 30 breaths per minute on 4 L/min entrains far more room air than a patient breathing at 12 breaths per minute, resulting in a substantially different effective FiO₂.
For the most reliable A-a gradient, either calculate on room air or use a fixed-performance oxygen delivery device (e.g., Venturi mask) that delivers a known FiO₂ regardless of breathing pattern. If a nasal cannula value must be used, document the flow rate and the estimated FiO₂, and recognise that the gradient calculation carries inherent imprecision.
At altitude, atmospheric pressure decreases, which reduces the calculated PAO₂ and therefore affects the A-a gradient. Using 760 mmHg (sea level) when the patient is at significant altitude (e.g., Denver at ~1,600m / ~630 mmHg, Mexico City at ~2,200m / ~580 mmHg, Bogotá at ~2,600m / ~560 mmHg) will systematically overestimate PAO₂ and produce a falsely widened A-a gradient.
Always use the local atmospheric pressure for the calculation. Many ABG analysers automatically correct for local barometric pressure, but manual calculations require the clinician to input the correct value. This calculator defaults to 760 mmHg but includes an editable atmospheric pressure field for altitude adjustment.
The A-a gradient framework assumes a binary distinction between extrapulmonary and intrapulmonary causes of hypoxaemia. In reality, many patients have both. A patient with COPD (elevated A-a gradient from V/Q mismatch) who is also on opioids (hypoventilation) will have a widened gradient from the COPD, but the hypoventilation component makes the hypoxaemia worse than the gradient alone would predict.
In mixed pathology, the A-a gradient will be elevated (reflecting the lung disease), but the PaCO₂ will also be elevated (reflecting hypoventilation). This combination — elevated A-a gradient plus hypercapnia — should trigger assessment for both an intrinsic lung process and a cause of hypoventilation. Do not assume that hypercapnia alone explains the hypoxaemia if the gradient is widened.
Quick Reference Summary
of Normal (mmHg)
Young Adults (mmHg)
Quotient (RQ)
(mmHg at 37°C)
| A-a Gradient | Interpretation | Think Of |
|---|---|---|
| Normal | Lungs are working — problem is extrapulmonary | Hypoventilation (drugs, NM disease), low FiO₂ (altitude) |
| Elevated | Lungs are the problem — impaired gas exchange | V/Q mismatch, shunt, diffusion impairment |
The Golden Rule: A normal A-a gradient in a hypoxaemic patient rules out intrinsic lung disease as the cause — redirect the workup to ventilation and inspired oxygen. Calculate on room air whenever possible for the most reliable interpretation.
Disclaimer & References
For Educational Purposes Only. This calculator and the accompanying clinical information are intended as educational tools for healthcare professionals. They do not replace clinical judgement. Results should be interpreted in the full clinical context. Lab reference ranges vary by institution — verify with your own laboratory. Drug dosages should be confirmed against current prescribing information.
References
- West JB. Respiratory Physiology: The Essentials. 10th ed. Philadelphia: Wolters Kluwer; 2016.
- Sarkar M, Niranjan N, Banyal PK. Mechanisms of hypoxemia. Lung India. 2017;34(1):47–60. DOI: 10.4103/0970-2113.197116
- Petersson J, Glenny RW. Gas exchange and ventilation-perfusion relationships in the lung. Eur Respir J. 2014;44(4):1023–1041. DOI: 10.1183/09031936.00037014
- Kanber GJ, King FW, Eshchar YR, Sharp JT. The alveolar-arterial oxygen gradient in young and elderly men during air and oxygen breathing. Am Rev Respir Dis. 1968;97(3):376–381. DOI: 10.1164/arrd.1968.97.3.376
- Mellemgaard K. The alveolar-arterial oxygen difference: its size and components in normal man. Acta Physiol Scand. 1966;67(1):10–20. DOI: 10.1111/j.1748-1716.1966.tb03281.x
- Harris EA, Kenyon AM, Nisbet HD, Seelye ER, Whitlock RM. The normal alveolar-arterial oxygen-tension gradient in man. Clin Sci Mol Med. 1974;46(1):89–104. DOI: 10.1042/cs0460089
- ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526–2533. DOI: 10.1001/jama.2012.5669